Categories: Patient Care

Antimicrobial drug management program succeeds through teamwork

Increasing resistance to antimicrobial drugs and a shortage of new antimicrobial drugs call for new ways to use them wisely. This is especially true in hospitals and medical centers where bacteria are prominent and can be easily spread. A model management program at the UCSF Medical Center, which...

Tech-check-tech becomes law

A new California law, effective January 5, 2007, is designed to give pharmacists more time to work directly with patients to ensure greater medication safety by allowing specially trained technicians to assume time-consuming tasks of filling and checking prescriptions. Research led by the UCSF...

Medicare Part D outreach funded by Amgen Foundation

The UCSF School of Pharmacy has received a US$3.7 million grant from the Amgen Foundation to train student pharmacists in all 7 California schools of pharmacy with the skills they need to help the underserved elderly make the best Medicare Part D choices.

Calls about the abuse of cold medicines increase tenfold in California

Calls to the California Poison Control System (CPCS) about abuse, primarily in adolescents, of over-the-counter medications containing the active ingredient dextromethorphan, increased tenfold from 1999 to 2004, according to a retrospective review published in the December 2006 issue of Archives of...

Gibson receives Chauncey I. Cooper Award

Robert D. Gibson, PharmD, UCSF School of Pharmacy alumnus and former associate dean, has been honored with the Chauncey I. Cooper Award by the National Pharmaceutical Association (NPhA) in recognition of his sustained and distinguished service to the profession of pharmacy.

Communication is key to medication adherence

Patients benefit best from medications when they take the right medicines at the right dose and at the right time.

Medicare Part D coverage gap can be a black hole for some seniors

In the new United States Medicare Part D prescription drug plan, most people are responsible for 100% of their drug costs after their annual drug expenses exceed US$2,250 and until their expenses reach US$5,100.

Part D insurers eye the bottom line

Helene Levens Lipton, PhD, UCSF School of Pharmacy faculty member and health policy expert, comments that insurers will remain in the Medicare Part D marketplace as long as they benefit.

Full story

Medicare Drug Plan is Prescribing Profits, Business Gains Could Diminish as Program Evolves 

More

Know your cholesterol numbers when considering a drug

Candy Tsourounis, PharmD, UCSF School of Pharmacy clinical faculty member and expert on herbals and dietary supplements, warns that depending upon your blood cholesterol levels, a cholesterol-lowering dietary supplement might not be enough for you. Listen to National Public Radio Morning Edition,...

Plan B under review again by the FDA

In light of the US Food and Drug Administration (FDA) July 31, 2006 announcement that it is proceeding to work toward making emergency contraception, known as Plan B, a non-prescription product for women ages 18 and older, two UCSF School of Pharmacy clinical faculty members answer questions about...

Pages